CompanyRLMDNasdaqCoral Gables, FL

Relmada Therapeutics, Inc.

Relmada Therapeutics develops therapies for oncology and central nervous system conditions.

SEC EDGAR ClinicalTrials.gov ir.relmada.com

8-KSep 8Latest SEC filing, period to Sep 3

Aug 6Latest story

August 2026

Relmada targets year-end IND filings for NDV-01 and sepranolone, reports $217.7M cash

Aug 6Quarterly updateRelmada Therapeutics, Inc.sustained-release gemcitabine-docetaxel

July 2026

Relmada names Bipin Dalmia as Chief Business Officer

Jul 28PeopleRelmada Therapeutics, Inc.sustained-release gemcitabine-docetaxel